Purpose Of Review: Nearly 1% of pregnancies are affected by some type of midtrimester oligohydramnios. Evidence is currently accumulating that suggests the better efficacy of the new therapeutic procedures relative to conventional management. This review summarizes the available evidence.
Recent Findings: The prolongation of the period between the diagnosis of oligohydramnios and delivery following amnioinfusion and amniopatch techniques appears to be strongly associated with the gestational age and whether the situation was based on rupture of the membranes or not. Case series reveal that amnioinfusion significantly improves the perinatal outcome and prolongs the pregnancy in severe second-trimester oligohydramnios in both idiopathic cases and those involving rupture of the amniotic membranes [preterm prelabor rupture of the membranes (PPROM)]. There is clear evidence of a lower frequency of perinatal complications and successfully prolonged gestation in iatrogenic PPROM after the amniopatch technique relative to population controls.
Summary: Identification of potentially modifiable risk factors for the successful prolongation of pregnancy complicated with midtrimester oligohydramnios, and previable PPROM is needed for the improvement of treatment strategies and prognosis. Randomized trials are needed to determine whether amniotic fluid-replenishing strategies can improve pregnancy outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/GCO.0000000000000051 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Placental mesenchymal dysplasia: a rare case associated with second trimester fetal growth restriction.
BMC Pregnancy Childbirth
November 2024
Obstetrics & Gynecology department, Whiston Hospital, Prescot, L35 5DR, UK.
Background: Placental mesenchymal dysplasia (PMD) is a rare, benign, placental disorder characterised macroscopically by an enlarged multi-cystic placenta. It is a condition associated with a range of reported clinical outcomes and can be misdiagnosed as a molar or partial molar pregnancy given the similarities in clinical presentation. We present an unusual case of PMD complicated by fetal growth restriction and oligohydramnios in the second trimester.
View Article and Find Full Text PDFThe correlation between placental growth factor and small for gestational age infants: a matched case-control study.
J Matern Fetal Neonatal Med
December 2024
Department of Pediatrics, Peking University People's Hospital, Beijing, China.
Background: At present, research has not found easily accessible, accurate, and safe clinical biomarkers that can effectively predict the occurrence of infants born small for gestational age (SGA). The aim of this study is to explore the predictive role of maternal placental growth factor (PIGF) levels on the occurrence of SGA infants.
Method: We conducted a matched case-control study on 226 SGA infants and 226 non-SGA infants born in the Department of Obstetrics, Peking University People's Hospital, from January 2021 to December 2022, with regular monitoring of maternal serum PIGF levels in second trimester during pregnancy.
Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term Impact.
Indian J Hematol Blood Transfus
October 2024
Department of Clinical Haematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Article Synopsis
- Diagnosing Chronic Myeloid Leukemia (CML) during pregnancy poses significant challenges, especially in low- and middle-income countries, with limited management data available.
- The study investigated outcomes for female patients diagnosed with CML-CP during pregnancy, analyzing medical records from 2002 to 2022, highlighting various pregnancy outcomes and treatment strategies.
- Among the thirteen patients examined, outcomes included five elective terminations, five pre-term deliveries, and three full-term deliveries, with a median follow-up showing that most maintained major molecular remission, illustrating the need for coordinated care between haematologists and obstetricians.
A rare cause of echogenic kidneys with oligohydramnios in the fetus: report of two different cases.
BMC Pregnancy Childbirth
October 2024
Department of Obstetrics and Gynecology, Chumphon Khet Udomsakdi Hospital and Clinical Medical Education Center, Chumphon, Thailand.
Article Synopsis
- Prenatal ultrasound showing echogenic kidneys and low amniotic fluid can be stressful, complicating predictions about outcomes and recurrence risks for future pregnancies.
- The report presents two cases of fetal echogenic kidneys; one was diagnosed postnatally with glomerulocystic kidney disease, while the other confirmed autosomal recessive polycystic kidney disease with a genetic mutation.
- The study emphasizes the need for accurate prenatal diagnosis and consideration of various conditions, like glomerulocystic kidney disease, to improve counseling and management for affected families.*
"An update on the approach to treatment of Sjogren's Disease in pregnancy".
J Matern Fetal Neonatal Med
December 2024
Jersey City Medical Center, Rutgers New Jersey Medical School, Newark, NJ, USA.
Article Synopsis
- Women with Sjögren's Disease face more pregnancy complications like hypertension, preterm delivery, and fetal growth issues compared to those without the disease.
- A significant concern is fetal autoimmune congenital heart block (ACHB), which can lead to severe outcomes like intrauterine fetal death and long-term developmental issues.
- The study emphasizes the importance of regular fetal echocardiograms for early detection of ACHB and discusses updated management strategies based on recent research findings.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!